A Phase 2 Randomized Open-Label Study of Oral ODM-201 vs. Androgen Deprivation Therapy (ADT) With LHRH Agonists or Antagonist in Men With Hormone Naive Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2018
At a glance
- Drugs Darolutamide (Primary) ; Degarelix; Goserelin; Leuprorelin; Triptorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- 24 Apr 2018 Planned End Date changed from 1 Jul 2021 to 1 May 2022.
- 24 Apr 2018 Planned primary completion date changed from 1 Mar 2020 to 1 Dec 2020.
- 24 Apr 2018 Status changed from not yet recruiting to recruiting.